Source: MarketScreener

Quantum Genomics: Quantum Genomics : Quantum Genomics announces that it has obtained the approval of Shareholders on the reduction of its share capital and on the contribution in kind of 100% of ExactCure's securities.

(marketscreener.com) The Quantum Genomics Company announces that, as part of its merger project with Exactcure, French HealthTech developing artificial intelligence software to adapt medication intake to the profile of each individual, the transactions concerning the reduction of its share capital and the contribution of 100% of ExactCure's shares were...https://www.marketscreener.com/quote/stock/QUANTUM-GENOMICS-16253203/news/Quantum-Genomics-Quantum-Genomics-announces-that-it-has-obtained-the-approval-of-Shareholders-46524454/?utm_medium=RSS&utm_content=20240425

Read full article »
Annual Revenue
$100K-5.0M
Employees
1-25
Jean-Philippe Milon's photo - CEO of Quantum Genomics

CEO

Jean-Philippe Milon

CEO Approval Rating

90/100

Read more